CVS Health Corporation
CVS
$95.16
$0.250.26%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.22% | 0.00% | 174.04% | -489.32% | -42.61% |
| Total Depreciation and Amortization | 0.99% | -2.79% | 1.15% | -3.16% | 1.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.78% | -41.12% | -93.84% | 37,100.00% | -92.86% |
| Change in Net Operating Assets | 109,800.00% | 100.20% | 35.01% | -408.41% | -121.65% |
| Cash from Operations | 49.33% | 25.34% | 325.88% | -58.04% | -58.36% |
| Capital Expenditure | 18.61% | -8.29% | -12.32% | -14.99% | 18.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 20.00% | 28.57% | 97.59% | -143.70% | -495.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,845.00% | 98.34% | -9.83% | -268.79% | -29,900.00% |
| Cash from Investing | -115.56% | 56.26% | 4.26% | -103.81% | -34.38% |
| Total Debt Issued | -- | -- | -100.00% | 230.94% | -- |
| Total Debt Repaid | -16.53% | -19.81% | 65.93% | -542.74% | 152.43% |
| Issuance of Common Stock | 10.68% | 19.77% | -26.50% | 148.94% | -67.36% |
| Repurchase of Common Stock | -1,511.11% | 30.77% | 35.00% | 82.46% | -936.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.66% | -0.24% | 0.12% | 2.31% | -3.10% |
| Other Financing Activities | 68.09% | -771.43% | -81.58% | 272.73% | 4.35% |
| Cash from Financing | -16.18% | -14.07% | -47.03% | -271.46% | 134.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.27% | 265.16% | 76.06% | -259.20% | 14.84% |